Literature DB >> 16378643

Expression of apoptosis-related proteins in peritoneal, ovarian and colorectal endometriosis.

Charlotte Dufournet1, Catherine Uzan, Raffaèle Fauvet, Annie Cortez, Jean-Pierre Siffroi, Emile Daraï.   

Abstract

Endometriosis is defined as the presence of endometrial glands and stroma outside the uterus. Apoptosis, a physiological process by which multicellular organisms eliminate superfluous cells, is altered in tumor tissue. Here we studied the expression of the apoptosis-related proteins p53, bcl-2, bax, p21 and fas in proliferative (n=9) and secretory (n=9) endometrium, and in peritoneal (n=11), ovarian (n=20) and colorectal (n=20) endometriosis, by qualitative and semi-quantitative immunohistochemical methods using the percentage of positive cells and HSCORE analysis. In endometrium, p53, p21 and fas expression was low, whereas bax and bcl-2 expression was elevated. Using HSCORE analysis, only bcl-2 expression varied during the menstrual cycle (48.9+/-34.2% in the proliferative phase, 11.5+/-24.7% in the secretory phase, p=0.01). Using HSCORE analysis, p53 expression was higher in ovarian endometriosis than in peritoneal (p<0.0001) and colorectal endometriosis (p=0.03). P21 expression was higher in ovarian endometriosis than in peritoneal (p=0.01) and colorectal endometriosis (p=0.01). Bcl-2 expression was lower in ovarian endometriosis than in peritoneal (p=0.0002) and colorectal endometriosis (p<0.0001). Fas expression was higher in peritoneal endometriosis than in ovarian (p=0.02) and colorectal endometriosis (p=0.008). In conclusion, these results confirm the involvement of apoptosis in the pathogenesis of endometriosis. Moreover, expression of apoptosis-related proteins varies according to the location of endometriosis suggesting the involvement of different apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378643     DOI: 10.1016/j.jri.2005.11.003

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  7 in total

1.  Indoleamine 2,3-dioxygenase-1 (IDO1) enhances survival and invasiveness of endometrial stromal cells via the activation of JNK signaling pathway.

Authors:  Jie Mei; Ming-Qing Li; Ding Ding; Da-Jin Li; Li-Ping Jin; Wei-Guo Hu; Xiao-Yong Zhu
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

2.  Mullerian inhibiting substance induces apoptosis of human endometrial stromal cells in endometriosis.

Authors:  Jeong Namkung; Jae Yen Song; Hyun Hee Jo; Mee Ran Kim; Young Oak Lew; Patricia K Donahoe; David T MacLaughlin; Jang Heub Kim
Journal:  J Clin Endocrinol Metab       Date:  2012-07-03       Impact factor: 5.958

Review 3.  Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis.

Authors:  Fernando M Reis; Felice Petraglia; Robert N Taylor
Journal:  Hum Reprod Update       Date:  2013-03-28       Impact factor: 15.610

4.  Phytochemical characteristics from Phaleria macrocarpa and its inhibitory activity on the peritoneal damage of endometriosis.

Authors:  Maharani Maharani; Lia Lajuna; Cut Yuniwati; Oktalia Sabrida; Sutrisno Sutrisno
Journal:  J Ayurveda Integr Med       Date:  2020-12-04

5.  Estrogen restricts the apoptosis of endometrial stromal cells by promoting TSLP secretion.

Authors:  Hui-Li Yang; Kai-Kai Chang; Jie Mei; Wen-Jie Zhou; Li-Bing Liu; Li Yao; Yi Meng; Ming-Yan Wang; Si-Yao Ha; Zhen-Zhen Lai; Jiang-Feng Ye; Da-Jin Li; Ming-Qing Li
Journal:  Mol Med Rep       Date:  2018-08-24       Impact factor: 2.952

6.  Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.

Authors:  Mohammad Hashemi; Aliakbar Fazaeli; Saeid Ghavami; Ebrahim Eskandari-Nasab; Farshid Arbabi; Mohammad Ali Mashhadi; Mohsen Taheri; Wiem Chaabane; Mayur V Jain; Marek J Łos
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

Review 7.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.